FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edscharp who wrote (8)	9/28/1999 12:24:00 PM
From: opalapril	Read Replies (1) of 75

Here is a link to a company I have followed for some time, Biomira Ltd. It is in Phase III clinical trials with Theratope for breast cancer. The interesting thing is they were given permission to use a formula 10x the strength of that used in P-2. I am not suggesting it is timely yet to invest in BIOM, much less that it is a solid investment. But I do believe it merits watching closely. BIOM biomira.com Below is from the ICOS thread last March, reporting on a conference call with ICOS. The poster's personal observations have proved prescient insofar as the two recently failed trials are concerned. Still, in my opinion ICOS bears watching, too, although in keeping with this thread's theme it is still too early to invest. ICOS Message 7607811

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next